Clinical Trial Update: MyoSense- Automated Muscle Hypertonicity Classification System

View source ↗

Summary

A clinical trial evaluating the MyoSense automated muscle hypertonicity classification system has completed, assessing its use in stroke, dystonia, and cerebral…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Dystonia
• Stroke

Drugs mentioned

• MyoSense Automated Muscle Hypertonicity Classification System

Snippet

Sponsor: Great Lakes NeuroTechnologies Inc. | Conditions: Stroke, Dystonia | Status: COMPLETED